Atrial Thrombosis Prevalence Before Cardioversion or Catheter Ablation of Atrial Fibrillation: An Updated Systematic Review and Meta-Analysis of Direct Oral …

F Troisi, P Guida, N Vitulano, F Quadrini… - The American Journal of …, 2024 - Elsevier
Left atrial or left atrial appendage thrombosis (LAT) is contraindicated for cardiac ablation
(CA) or cardioversion (CV) of atrial fibrillation (AF). This study was aimed to compare the …

Safety and efficacy of apixaban versus vitamin K antagonists in patients undergoing dialysis: a systematic review and meta-analysis

Y Zhang, J Wang, N Shen, J Jiang, Y Xie - Renal Failure, 2024 - Taylor & Francis
Background This review aims to evaluate the safety and efficacy of apixaban vs. vitamin K
antagonists (VKAs) in patients on dialysis. Methods All types of studies published on …

[HTML][HTML] The desirable effects of edoxaban on thrombi in the left atrium are seemingly connected to pulmonary vein thrombi

H Takeuchi - Cureus, 2024 - ncbi.nlm.nih.gov
Ischemic stroke (IS) causes various degrees of disability that sometimes induce social
problems: therefore, preventing the occurrence and recurrence of IS is important. The …

Contemporary trends in incident ischemic stroke, intracranial hemorrhage, and mortality in individuals with atrial fibrillation

JJ Noubiap, JJ Tang, TA Dewland… - … Heart Journal-Quality …, 2024 - academic.oup.com
Background The prognosis for atrial fibrillation (AF) patients is based on data that is decades
old. Given evolving standards of clinical practice, we sought to evaluate temporal trends in …

Outcomes of Direct Oral Anticoagulants with Aspirin Versus Warfarin with Aspirin: A Registry Based Cohort Study

JK Schaefer, J Errickson, X Kong, MA Ali… - Research and Practice …, 2024 - Elsevier
Background For patients anticoagulated with direct oral anticoagulants (DOAC) or warfarin
and on aspirin (ASA) for non-valvular atrial fibrillation (AF) and/or venous thromboembolism …

[HTML][HTML] Reducing Adverse Drug Events Related to Anticoagulant Use in Adults

JR Treadwell, C Jepson, I Ivlev… - Making Healthcare Safer …, 2024 - ncbi.nlm.nih.gov
1. Background and Purpose The Agency for Healthcare Research and Quality (AHRQ)
Making Healthcare Safer (MHS) reports consolidate infonnation for healthcare providers …

[HTML][HTML] Non-traumatic Rectus Sheath Hematoma During Direct Oral Anticoagulation

T Hideyama, E Watanabe, N Ido, H Terashi, H Aizawa - Cureus, 2023 - ncbi.nlm.nih.gov
We report a case of anticoagulation therapy complicated by a non-traumatic rectus sheath
hematoma (RSH). RSH is a relatively rare occurrence caused by bleeding into the rectus …

Comparison of Oral Anticoagulants vs. Warfarin for Stroke Prevention in Atrial Fibrillation: A Meta-Analysis: Oral Anticoagulants vs. Warfarin in AF: A Meta Analysis

O Tahir, I Saleem, R Adnan, L Kumari… - Journal of Health and …, 2024 - jhrlmc.com
Background: Atrial fibrillation (AF) significantly increases the risk of ischemic stroke,
necessitating effective anticoagulation therapy. Warfarin has been the standard treatment …

[PDF][PDF] MUDr. David Franc

LFU PALACKÉHO, V OLOMOUCI - theses.cz
9. Publikační a přednášková aktivita 90 9.1. Původní vědecké publikace související s
disertační prací uveřejněné in extenso v recenzovaných vědeckých časopisech s IF 90 9.2 …